Skip to main content
OpenTrials

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

9,146 public trials 1,797 recruiting studies
Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Recruiting

A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis

NCT07250750

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations
  • Neurology of Central Florida Research Center, LLC Altamonte Springs, Florida, United States
  • SFM Clinical Research, LLC Boca Raton, Florida, United States
  • Aqualane Clinical Research Naples, Florida, United States
  • Medsol Clinical Research Center Port Charlotte, Florida, United States
View all 25 locations
View Trial Details
Recruiting

Study of ATX-01 in Participants With DM1

NCT06300307

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +10 more
Locations
  • UCLA Los Angeles, California, United States
  • University of Florida Gainesville, Florida, United States
  • University of Iowa Health Care - Department of Neurology Iowa City, Iowa, United States
  • University of Kansas Medical Center, Department of Neurology Fairway, Kansas, United States
View Trial Details
Recruiting

Intermuscular Coherence as a Biomarker for ALS

NCT05104710

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • University of California Center for Clinical Research Irvine, California, United States
  • University of Miami Miller School of Medicine Miami, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University Medical Center St Louis, Missouri, United States
View Trial Details
Recruiting

Combined Metabolic Activator Supplementation in Subjects Diagnosed With Alzheimer's Disease

NCT07062198

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • Department of Neurology and Neuroscience, Faculty of Medicine, Alaaddin Keykubat University Alanya, Turkey (Türkiye)
  • Ataturk University, Faculty of Medicine, Department of Neurology, Erzurum, Turkey; Movement Disorders and Neuromodulation Center, Ataturk University Erzurum, Turkey (Türkiye)
  • Behavioural Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University Istanbul, Turkey (Türkiye)
  • Haydarpaşa Numune Training and Research Hospital, University of Health Sciences Istanbul Istanbul, Turkey (Türkiye)
View Trial Details

Related conditions